当前位置:首页 - 行情中心 - 凯赛生物(688065) - 财务分析 - 资产负债表

凯赛生物

(688065)

  

流通市值:214.80亿  总市值:265.58亿
流通股本:5.83亿   总股本:7.21亿

资产负债表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
流动资产:
  货币资金8,623,156,126.229,297,803,059.049,405,030,835.769,251,568,474.45
  交易性金融资产151,336,816.65469,248469,248469,248
  应收票据及应收账款617,784,730.27543,941,407.54470,084,468.45440,074,975.97
  其中:应收票据149,992,069.97122,860,419.95124,236,456.58142,579,117.59
        应收账款467,792,660.3421,080,987.59345,848,011.87297,495,858.38
  应收款项融资83,683,545.8258,237,129.92359,760,744.9379,736,532.73
  预付款项138,816,869.2888,234,912.0482,503,448.0378,779,918.59
  其他应收款合计6,984,279.143,448,157.55,545,558.327,772,423.5
  存货1,553,396,237.671,406,558,566.041,401,033,381.241,440,116,190.87
  其他流动资产603,890,162.65564,698,745.55542,086,708.74432,875,681.27
  流动资产合计11,779,048,767.711,963,391,225.6312,266,514,393.4711,731,393,445.38
非流动资产:
  长期股权投资188,434,279.35194,610,094.14199,914,262.41203,674,594.05
  固定资产3,457,800,925.133,524,693,584.533,590,822,784.43,654,120,244.24
  在建工程7,103,204,320.686,898,768,318.336,742,391,203.816,600,655,073.42
  使用权资产1,204,109.88---
  无形资产742,037,045.74748,735,574.21723,693,464.13728,504,420.69
  商誉237,952,142.03237,952,142.03--
  长期待摊费用2,514,826.023,366,284.776,075,520.663,207,339.9
  递延所得税资产292,658,703.09285,894,002.21282,304,459.9278,118,201.53
  其他非流动资产808,153,107.56754,998,006.58745,486,636.62682,609,653.85
  非流动资产合计12,833,959,459.4812,649,018,006.812,290,688,331.9312,150,889,527.68
  资产总计24,613,008,227.1824,612,409,232.4324,557,202,725.423,882,282,973.06
流动负债:
  短期借款409,574,859.46294,043,287.18761,509,799.51301,223,184.45
  应付票据及应付账款1,315,191,970.451,374,932,703.211,347,006,834.711,403,724,038.58
        应付账款1,315,191,970.451,374,932,703.211,347,006,834.711,403,724,038.58
  预收款项4,121,832.22297,431.21,007,734.872,663,954.9
  合同负债27,466,704.6726,725,437.6559,404,046.430,608,805.69
  应付职工薪酬19,229,671.9114,400,485.669,533,697.8324,463,952.37
  应交税费41,224,159.8534,674,492.3940,698,051.8438,994,006.53
  其他应付款合计204,893,553.87494,668,992.48146,669,104.01188,158,209.08
        应付股利831,600324,872,007.3831,600831,600
  一年内到期的非流动负债37,384,175.4636,149,456.7228,126,625.7412,809,312.2
  其他流动负债3,570,671.613,474,306.897,722,526.033,853,606.34
  流动负债合计2,062,657,599.52,279,366,593.382,401,678,420.942,006,499,070.14
非流动负债:
  长期借款442,590,193.91377,511,894.99303,435,314.68188,963,845.31
  租赁负债1,281,833.84---
  递延收益352,381,540.93360,204,667.63366,841,138.62371,976,134.22
  递延所得税负债6,915,103.487,124,230.38--
  非流动负债合计803,168,672.16744,840,793670,276,453.3560,939,979.53
  负债合计2,865,826,271.663,024,207,386.383,071,954,874.242,567,439,049.67
所有者权益(或股东权益):
  实收资本(或股本)721,289,794721,289,794721,289,794721,289,794
  资本公积14,259,428,724.5814,255,112,092.5314,250,396,810.4914,245,681,528.54
  减:库存股109,056,939.1109,056,939.1109,056,939.1109,056,939.1
  其他综合收益1,643,320.552,787,565.863,095,913.22,936,809.38
  专项储备25,387,857.823,732,406.1521,262,940.6220,235,258.64
  盈余公积240,367,413.62240,367,413.62240,367,413.62240,367,413.62
  未分配利润2,781,215,905.062,626,990,737.622,744,017,373.632,578,300,500.66
  归属于母公司股东权益合计17,920,276,076.5117,761,223,070.6817,871,373,306.4617,699,754,365.74
  少数股东权益3,826,905,879.013,826,978,775.373,613,874,544.73,615,089,557.65
  股东权益合计21,747,181,955.5221,588,201,846.0521,485,247,851.1621,314,843,923.39
  负债和股东权益合计24,613,008,227.1824,612,409,232.4324,557,202,725.423,882,282,973.06
公告日期2026-10-312026-08-202026-04-302026-04-24
审计意见(境内)标准无保留意见
TOP↑